Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence

Mol Psychiatry. 1998 Jul;3(4):333-6. doi: 10.1038/sj.mp.4000409.

Abstract

Anatomical, pharmacological and human post-mortem studies suggest the dopamine D3 receptor (DRD3) gene as a candidate for drug dependence. We thus performed an association study of the Bal I polymorphism at the DRD3 gene, including 54 opiate addicts and 70 controls. Opiate addicts had a higher sensation-seeking score (on the Zückerman scale) than controls (P = 0.001), particularly a subgroup (70%) who had a distinctly higher score, exceeding 24. There were no marked differences in genotypes between patients as a whole and controls. However, patients with a sensation-seeking score above 24 were more frequently homozygotes for both alleles than patients with a sensation-seeking score under 24 (P = 0.038) or controls (P = 0.034). Although obtained in a sample of limited size, these results suggest that the DRD3 gene may have a role in drug dependence susceptibility in individuals with high sensation-seeking scores. This hypothesis is consistent with the role of DRD3 in mediating responses to drugs of abuse in animals and the association of homozygosity at the Bal I polymorphism with drug abuse in schizophrenic patients (see companion article by Krebs et al).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Deoxyribonucleases, Type II Site-Specific
  • France
  • Genotype
  • Homozygote*
  • Humans
  • Male
  • Morbidity
  • Opioid-Related Disorders / epidemiology
  • Opioid-Related Disorders / genetics*
  • Personality / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length*
  • Receptors, Dopamine D2 / genetics*
  • Receptors, Dopamine D3
  • Reference Values

Substances

  • DRD3 protein, human
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Deoxyribonucleases, Type II Site-Specific
  • TGGCCA-specific type II deoxyribonucleases